Nomogram for 5-year relapse-free survival of a patient with advanced gastric cancer after surgery

Abstract

We developed and validated a nomogram to predict 5-year RFS after curative surgery for stage II/III gastric cancer. This tool will be useful for the assessing a patient's individual recurrence risk when considering additional therapy in clinical practice.